Ilika plc Q2 2026 Earnings Recap

Ilika plc reported strong progress in its half-year results, highlighting milestone achievements in solid-state battery development and initial commercial orders, underpinning a solid foundation for future growth.

Key Takeaways

• Successfully completed an equity raise, bolstering capital for operational stability and growth.
• Achieved initial commercial orders for Stereax batteries, indicating market acceptance and ramp-up in production.
• Goliath product line reached product prototyping stage, with ongoing trials to convert prototypes into minimum viable products for the EV and automotive sectors.
• Continued strong pipeline of intellectual property with 78 patents granted, enhancing the company's competitive positioning in solid-state battery technology.
• Established strategic collaboration with Cirtec Medical for Stereax, integrating battery solutions into broader power management systems for neurostimulation applications.